focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commercial Launch in China

27 Jan 2014 07:00

RNS Number : 5282Y
Phorm Corporation Limited
27 January 2014
 

27 January 2014

 

Phorm Corporation Limited

("Phorm" or the "Company")

 

Commercial Launch in China and Global Operations Update

Phorm (AIM: PHRM), a leading internet personalisation technology company, is pleased to announce that it is now serving advertisements in the People's Republic of China and continues to make excellent progress with its other global operations.

 

Highlights:

· Launch of commercial operations in China serving paid advertisements

· Operational launch achieved with 5 further ISPs since TTNET in Turkey

· Daily global user numbers are now in excess of 20 million

· Inventory deals provide access to over 80 billion page impressions per month

· Market leading conversion rates

· Gross revenue for Q4 2013 up 125% on the previous quarter

 

Phorm announced on 3 October 2013 that it had launched operationally in China and had commenced a nation-wide opt-in process. The Company is now pleased to announce that it has commenced commercial operations in China and is serving advertisements on a paid basis.

 

Since launching with TTNET, a subsidiary of Türk Telecom Group, in Turkey in 2012, Phorm has now successfully launched its platform with 5 further ISPs. Accordingly, on a global basis, there are now over 20 million daily users on Phorm's platform.

 

The Company is also pleased to announce that it has now achieved access to over 80 billion monthly advertising impressions, on a global basis, from its publisher partners.

 

In terms of revenue generation, campaigns in Turkey are increasing in both size and volume. Gross consolidated revenue in Q4 2013 increased 125% quarter on quarter. Phorm has worked with all of the top 10 advertising agencies in Turkey running campaigns for over 300 local and global brands driven by market leading conversion rates.

 

The Company currently anticipates revenue to increase significantly as the growth in global user numbers accelerates with the expected launch of operations with new ISPs and in new potential markets.

 

As previously announced, the Company intends to provide the market with further updates on its key performance indicators (user numbers and revenue) on a quarterly basis which will be reported on a consolidated group basis in line with its current global activities.

 

-Ends-

 

For further information please contact:

 

Phorm Corporation Limited

Andy Croxson (analysts and investors) +44 (0) 203 397 6001

 

UK Investors

Mirabaud Securities LLP +44 20 7321 2508 (Broker)

Jason Woollard

Peter Krens

 

Strand Hanson Limited +44 20 7409 3494 (Nominated Adviser)

James Harris

Matthew Chandler

James Dance

 

US Investors

Lippert/Heilshorn and Associates +1 212 838 3777 (Investor Relations)

John Heilshorn

 

About Phorm

 

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's industry leading technology enables its ISP partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.

 

Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Unlike virtually all other targeted advertising propositions, Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Advertising Networks and Advertisers.

 

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

 

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEDEDMFLSEIF
Date   Source Headline
9th Jun 20068:58 amPRNAdditional Listing
8th Jun 20067:00 amPRNDirector/PDMR Shareholding
5th Jun 200611:03 amPRNDirector/PDMR Shareholding
1st Jun 20064:40 pmPRNDirector/PDMR Shareholding
25th May 20067:00 amPRNTrading in and settlement of Common Shares
17th May 20067:00 amPRNAdditional Listing
27th Apr 200612:17 pmPRNDirector/PDMR Shareholding
20th Apr 20069:33 amPRNDirector/PDMR Shareholding
19th Apr 20067:00 amPRNFinal Results
6th Feb 20067:00 amPRNIssue of Equity
3rd Feb 20067:01 amPRNBlocklisting
3rd Feb 20067:00 amPRNBlocklisting
12th Jan 20067:00 amPRNTrading Update
28th Dec 20057:00 amPRNHolding(s) in Company
5th Dec 20057:00 amPRNDirectorate Change
11th Nov 20057:00 amPRNStatement re wireless ISP agreement
30th Sep 20057:31 amPRNInterim Results
8th Aug 20053:18 pmPRNResult of Stockholders Meeting
29th Jul 200510:20 amPRNAdditional Listing
22nd Jul 20059:22 amPRNPlacing to raise approx GBP1m
14th Jul 20056:00 amPRNAdditional Listing
23rd Jun 20052:46 pmPRNResult of AGM
23rd Jun 20058:55 amPRNAGM Statement
14th Jun 20053:37 pmPRNDirector Shareholding
4th May 20056:00 amPRNStatement re New Technology
21st Apr 20056:00 amPRNFinal Results
21st Apr 20056:00 amPRNDirectorate Change
4th Apr 200510:12 amPRNCorrection : Change of Adviser
4th Apr 20059:05 amPRNChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.